Method for the treatment of benign prostatic hypertrophy

摘要

The present invention is concerned with a method for the treatment of benign prostatic hypertrophy in male humans, comprising administering an effective amount of a compound selected from the group consisting of partricin, C1-C6 alkyl ester of partricin and C1-C6 alkyl ester of N-mono- and N,N-disubstituted partricin, the N-substituents being C1-C6 alkyl or carboxylic acyl, to a human male suffering from benign prostatic hypertrophy.